NPRHealth
Human data hints psychedelics may fight inflammation
Early human research suggests psychedelics such as psilocybin may reduce inflammation, building on laboratory findings. The results point to possible benefits for people with neurodegenerative conditions, including Parkinson’s disease, but more research is needed to establish safety and effectiveness.
This card is an AI-assisted summary of reporting published by NPR. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.